Quadria-Backed Maxivision Secures Investment Bankers for Upcoming IPO Launch!
Maxivision Super Specialty Eye Hospitals has formally announced its intention to launch an Initial Public Offering (IPO) as part of its strategy to capitalize on the growing demand for specialized healthcare services in India, particularly in the ophthalmology segment. Appointing ICICI Securities and IIFL Capital as lead investment bankers, the company aims to structure its offering for 2027 after initial discussions indicated a possible late-2026 listing. The specifics of the IPO, including the issue size, remain undisclosed but will include a fresh issue of shares alongside an Offer for Sale (OFS) from existing investors, reflecting strong corporate backing and growth ambitions.
Founded in 1996 and spearheaded by Dr. G.S.K. Velu, Maxivision operates over 90 eye-care centers primarily in Southern India and is expanding into high-growth markets such as Gujarat, Maharashtra, and Madhya Pradesh. Funded by a substantial capital infusion from Quadria Capital, the company’s innovative approach of utilizing a “Doctor-Entrepreneur” partnership model positions it favorably within the competitive landscape of Indian healthcare. Financial forecasts show promising growth, with expected revenues reaching INR 500 crore in FY26 and a target of INR 800 crore by FY27, coupled with stable operating margins and a strong solvency profile, indicating readiness for public market scrutiny.
For Indian investors, Maxivision’s upcoming IPO symbolizes not only an opportunity to engage with the burgeoning healthcare sector but also a stake in a business model that prides itself on expansion and operational efficiency. Given the projected growth of India’s eye-care market from USD 12.8 billion in 2025 to USD 31.2 billion by 2033, demand for innovative healthcare solutions can be expected to rise. Investors will be particularly keen on how Maxivision’s asset-light model compares to peers such as Dr. Agarwal’s Health Care, as it could signal a shift in how healthcare companies adapt to market dynamics. With a keen focus on demonstrating immediate financial benefits from its expansion strategy, Maxivision could position itself as a leading player in India’s healthcare space.
Source: The Economic Times
(Expert Note: This report was prepared by the Wealthova IPO team.)